HIND is the ticker symbol for Vyome Holdings, Inc, a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks HIND with AI-powered analysis, a 32-signal quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Is HIND a good stock to buy?

HIND is tracked on 13F Pro with SEC EDGAR data, but is not currently included in our 32-signal AI quality ranking. The full company profile with financials and AI insights is at https://13fpro.ai/company/HIND.

Where does 13F Pro source HIND data?

All Vyome Holdings, Inc fundamentals and ownership data come directly from SEC EDGAR. Vyome Holdings, Inc files with the SEC under CIK 1427570. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

Vyome Holdings, Inc(HIND)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Vyome Holdings, Inc (HIND) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. HIND is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $13.6m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), Vyome Holdings, Inc reports quarterly revenue of $27.0K, net income of $-685.6K. Top institutional holders of HIND by reported 13-F value include CITADEL ADVISORS, GEODE CAPITAL MANAGEMENT, HRT FINANCIAL, based on the most recent SEC filings. HIND trades on the Nasdaq exchange and files with the SEC under CIK 1427570. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HIND daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Vyome Holdings, Inc directly from SEC EDGAR.

Revenue

$27.0K

Net Income

$-685.6K

HIND key financials by period

Vyome Holdings, Inc reported revenue, net income and margins by fiscal period, from SEC filings.
Period	Form	Revenue	Net income	Operating margin
FY 2025	10-K	$319.7K	$-10.3M	—
FY 2024	10-K	$256.9K	$-1.4M	—
FY 2023	10-K	$8.7M	$-11.4M	-177.3%
FY 2022	10-K	$11.2M	$-46.2M	—
FY 2021	10-K	$13.6M	$-63.1M	—
FY 2020	10-K	$11.3M	$-21.6M	-110.3%

Institutions holding HIND

Institutional investors reporting a position in Vyome Holdings, Inc on SEC Form 13F.
Institution	Shares	Value	Reported
CITADEL ADVISORS	25,972	$55.8K	2026-06-30
GEODE CAPITAL MANAGEMENT	25,793	$55.5K	2026-06-30
HRT FINANCIAL	20,318	$43.0K	2026-06-30
Focus Partners Wealth	14,640	$31.5K	2026-06-30
VANGUARD FIDUCIARY	12,195	$26.2K	2026-06-30
UBS Group AG	11,908	$25.6K	2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP	10,058	$21.6K	2026-06-30
VANGUARD CAPITAL MANAGEMENT	9,463	$20.3K	2026-06-30
ROYAL BANK OF CANADA	5,856	$13.0K	2026-06-30
Tower Research Capital (TRC)	1,808	$3.9K	2026-06-30

SEC EDGAR: CIK 1427570 →

Vyome Holdings, Inc

HIND

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $13.6M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.